These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 24499657
1. Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer. Bodnar L, Stanczak A, Cierniak S, Smoter M, Cichowicz M, Kozlowski W, Szczylik C, Wieczorek M, Lamparska-Przybysz M. J Ovarian Res; 2014 Feb 06; 7():16. PubMed ID: 24499657 [Abstract] [Full Text] [Related]
2. Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer. Nagy B, Tóth L, Molnár P, Méhes G, Thurzó L, Póka R, Hernádi Z. Pathol Res Pract; 2017 Aug 06; 213(8):915-921. PubMed ID: 28651933 [Abstract] [Full Text] [Related]
3. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma. Liew PL, Hsu CS, Liu WM, Lee YC, Lee YC, Chen CL. Int J Clin Exp Pathol; 2015 Aug 06; 8(5):5642-9. PubMed ID: 26191276 [Abstract] [Full Text] [Related]
4. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM. J Clin Pathol; 2006 May 06; 59(5):460-7. PubMed ID: 16461565 [Abstract] [Full Text] [Related]
5. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study. Prins MJ, Ruurda JP, Lolkema MP, Sitarz R, Ten Kate FJ, van Hillegersberg R. J Clin Pathol; 2015 Jul 06; 68(7):529-35. PubMed ID: 25855799 [Abstract] [Full Text] [Related]
6. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma. Zhang H, Liu J, Yue D, Gao L, Wang D, Zhang H, Wang C. J Clin Pathol; 2013 Nov 06; 66(11):937-45. PubMed ID: 23853314 [Abstract] [Full Text] [Related]
7. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis. Yang X, Sun J, Xia D, Can X, Liu L, Zhang J, Xu H, Du N, Liu W, Shen F, Zhang Z, Sun Y, Xi X. Cell Physiol Biochem; 2017 Nov 06; 42(1):185-197. PubMed ID: 28535511 [Abstract] [Full Text] [Related]
8. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival. Kamposioras K, Konstantara A, Kotoula V, Lakis S, Kouvatseas G, Akriviadis E, Vrettou E, Dionysopoulos D, Krikelis D, Papadopoulou K, Charalambous E, Chrisafi S, Konstantaras C, Fountzilas G. Anticancer Res; 2013 Oct 06; 33(10):4573-84. PubMed ID: 24123033 [Abstract] [Full Text] [Related]
9. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance. Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S, DiFeo A. Oncotarget; 2015 Sep 15; 6(27):23720-34. PubMed ID: 26125441 [Abstract] [Full Text] [Related]
10. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer. Kaltofen T, Preinfalk V, Schwertler S, Fraungruber P, Heidegger H, Vilsmaier T, Vattai A, Czogalla B, Mayr D, Mahner S, Jeschke U, Trillsch F. J Cancer Res Clin Oncol; 2020 Oct 15; 146(10):2559-2574. PubMed ID: 32681294 [Abstract] [Full Text] [Related]
11. Impact of an altered Wnt1/β-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma. Kruck S, Eyrich C, Scharpf M, Sievert KD, Fend F, Stenzl A, Bedke J. Int J Mol Sci; 2013 May 24; 14(6):10944-57. PubMed ID: 23708097 [Abstract] [Full Text] [Related]
12. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer. Bačić B, Haller H, Mrklić I, Košta V, Čarić A, Tomić S. Arch Gynecol Obstet; 2013 Jun 24; 287(6):1219-24. PubMed ID: 23269354 [Abstract] [Full Text] [Related]
13. The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer. Huang KJ, Sui LH. Med Oncol; 2012 Mar 24; 29(1):318-23. PubMed ID: 21264536 [Abstract] [Full Text] [Related]
14. Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma. Stanczak A, Stec R, Bodnar L, Olszewski W, Cichowicz M, Kozlowski W, Szczylik C, Pietrucha T, Wieczorek M, Lamparska-Przybysz M. Pathol Oncol Res; 2011 Dec 24; 17(4):955-63. PubMed ID: 21678109 [Abstract] [Full Text] [Related]
15. Expression and clinical significance of Wnt-1 and beta-catenin in nasopharyngeal carcinoma. Wang FL, Guo X, Yuan TZ, Cao SM, Rao HL, Hou JH, Shao Q, Li NW, Hong MH. Ai Zheng; 2009 Jan 24; 28(1):72-5. PubMed ID: 19448422 [Abstract] [Full Text] [Related]
16. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer. Omichi C, Nakamura K, Haraga J, Masuyama H, Hiramatsu Y. Cancer Med; 2016 Jun 24; 5(6):1074-80. PubMed ID: 26929186 [Abstract] [Full Text] [Related]
17. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava. Spachmann PJ, Breyer J, Kalogirou C, Lausenmeyer EM, Weber F, Prohaska S, Denzinger S, Burger M, Kübler H, Otto W, Vergho D. Urol Int; 2019 Jun 24; 102(4):413-420. PubMed ID: 30844790 [Abstract] [Full Text] [Related]
18. Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines. Bodnar L, Stec R, Cierniak S, Synowiec A, Wcisło G, Jesiotr M, Koktysz R, Chrom P, Szczylik C. Clin Genitourin Cancer; 2018 Aug 24; 16(4):257-265. PubMed ID: 29483043 [Abstract] [Full Text] [Related]
19. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance. Ayed-Guerfali DB, Hassairi B, Khabir A, Sellami-Boudawara T, Gargouri A, Mokdad-Gargouri R. Tumour Biol; 2014 Mar 24; 35(3):1775-83. PubMed ID: 24197976 [Abstract] [Full Text] [Related]
20. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer. Liu M, Mor G, Cheng H, Xiang X, Hui P, Rutherford T, Yin G, Rimm DL, Holmberg J, Alvero A, Silasi DA. Reprod Sci; 2013 May 24; 20(5):605-15. PubMed ID: 23171677 [Abstract] [Full Text] [Related] Page: [Next] [New Search]